A randomized single-center observational clinical study was carried out for one year in ACS patients'above18 years who underwent Percutaneous Coronary Intervention.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 10 Nov 2019

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Ticagrelor (Primary) ; Clopidogrel
Indications Acute coronary syndromes; Myocardial infarction; Thrombosis; Vascular disorders
Focus Therapeutic Use

10 Nov 2019 New trial record
06 Nov 2019 Primary endpoint (Death Rate) has not been met, according to results presented at 22nd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research.
06 Nov 2019 Results presented at the 22nd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com